1. Home
  2. SNDA vs ANAB Comparison

SNDA vs ANAB Comparison

Compare SNDA & ANAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sonida Senior Living Inc.

SNDA

Sonida Senior Living Inc.

HOLD

Current Price

$41.69

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

ANAB

AnaptysBio Inc.

HOLD

Current Price

$54.15

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SNDA
ANAB
Founded
1990
2005
Country
United States
United States
Employees
5140
N/A
Industry
Hospital/Nursing Management
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
1.3B
IPO Year
1997
2015

Fundamental Metrics

Financial Performance
Metric
SNDA
ANAB
Price
$41.69
$54.15
Analyst Decision
Buy
Buy
Analyst Count
4
12
Target Price
$35.75
$71.67
AVG Volume (30 Days)
626.6K
826.6K
Earning Date
05-11-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
91.02
EPS
N/A
N/A
Revenue
$381,141,000.00
$234,603,000.00
Revenue This Year
$68.73
N/A
Revenue Next Year
$11.11
$52.14
P/E Ratio
N/A
N/A
Revenue Growth
25.24
157.01
52 Week Low
$23.78
$17.11
52 Week High
$42.79
$73.30

Technical Indicators

Market Signals
Indicator
SNDA
ANAB
Relative Strength Index (RSI) 59.88 42.82
Support Level $30.78 $52.32
Resistance Level $42.79 $57.70
Average True Range (ATR) 1.53 4.96
MACD -0.12 -1.24
Stochastic Oscillator 82.21 17.92

Price Performance

Historical Comparison
SNDA
ANAB

About SNDA Sonida Senior Living Inc.

Sonida Senior Living Inc is an owner-operator of senior housing communities in the United States in terms of resident capacity. It provides senior living services to the elderly, including independent living, assisted living, Respite Care and Temporary Care Programs, Home Care Services, and memory care services. The company's objective is to provide value to residents by providing quality senior housing services at reasonable prices. The basic services offered by the company at its senior housing communities comprise meals, housekeeping, laundry, 24-hour staffing, transportation, social and recreational activities, and healthcare monitoring.

About ANAB AnaptysBio Inc.

AnaptysBio Inc is a clinical-stage biotechnology company. The company is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company is developing immune cell modulating antibodies, including two wholly owned checkpoint agonists in clinical-stage development, for autoimmune and inflammatory diseases; rosnilimab, PD-1 agonist in a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA) and a Phase 2 trial for the treatment of moderate-to-severe ulcerative colitis (UC); and ANB032, BTLA agonist, in a Phase 2b trial for the treatment of moderate-to-severe atopic dermatitis (AD).

Share on Social Networks: